Correlation Between NYSE Composite and Actinium Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Actinium Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Actinium Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Actinium Pharmaceuticals
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Actinium is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Actinium Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Actinium Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.15 times more return on investment than Actinium Pharmaceuticals. However, NYSE Composite is 6.64 times less risky than Actinium Pharmaceuticals. It trades about 0.27 of its potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest 1,945,669 in NYSE Composite on August 30, 2024 and sell it today you would earn a total of 75,313 from holding NYSE Composite or generate 3.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Actinium Pharmaceuticals
Performance |
| Timeline |
NYSE Composite and Actinium Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Actinium Pharmaceuticals
Pair trading matchups for Actinium Pharmaceuticals
Pair Trading with NYSE Composite and Actinium Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.| NYSE Composite vs. Sphere Entertainment Co | NYSE Composite vs. Weibo Corp | NYSE Composite vs. BCE Inc | NYSE Composite vs. Pinterest |
| Actinium Pharmaceuticals vs. Mink Therapeutics | Actinium Pharmaceuticals vs. Affimed NV | Actinium Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Actinium Pharmaceuticals vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |